How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

99

HKG:9960
Get a brief AI stock analysisSaves ~ 15 minutes of your time

99

Kindstar Globalgene Technology IncHKG 9960 Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XHKG - Hong Kong Exchange

FAIR VALUE

Is 9960 undervalued compared to its fair value?

The fair value of 9960 stock is hidden HKD. Relative to the market price of 1.3 HKD Kindstar Globalgene Technology Inc is hidden.

Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. The company is headquartered in Wuhan, Hubei and currently employs 3,052 full-time emplo...[More about valuation]

Kindstar Globalgene Technology Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.171 $B

Price:

1.3 HKD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.045

FINANCIALS

Kindstar Globalgene Technology financial for reporting period

Income Statement

0.49 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.044 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.49 B 100%
0.24 B 50%
0.044 B 9%

Balance Sheet

3.8 B
2.9 B

Financial Position Analysis

Assets

3.8 B
Current Assets
2.9 B
Total non-current assets
0.91 B

Total current liabilities
0.8 B
Total non-current liabilities
0.06 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0076 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Kindstar Globalgene Technology fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

2 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
6 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
2 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Kindstar Globalgene Rating

Is 9960 attractive for investment based on fundamental analysis?

9960 stock rating is hidden. Kindstar Globalgene Technology is a hidden by Eyestock methodology.

Get 9960 Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

5

Gross Margin:

45

CFO / Debt ratio:

hidden

Current ratio:

3.375

Debt / Equity ratio:

0.076

ROE:

2

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

9960.HK analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for 9960.HK to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Kindstar Globalgene Technology Inc dividends

Kindstar Globalgene Technology Inc dividend yield is 1.77%

The annual dividend is 0.03 HKD

9960.HK dividend metrics

Payout ratio
43.50%
Dividend yield
1.77%
Annual dividend
0.03
Dividend streak
1 year
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About 9960.HK stock

About the company Kindstar Globalgene Technology Inc

Market cap $B

0.171

Dividend yield

1.77 %

Shares outstanding

981.0815 B

Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. The company is headquartered in Wuhan, Hubei and currently employs 3,052 full-time employees. The company went IPO on 2021-07-16. The firm operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.

9960.HK profile

  • Ticker

    9960.HK

  • Country

    China

  • Exchange

    XHKG - Hong Kong Exchange

  • Report currency

    CNY - Chinese yuan

  • IPO date

    16 July 2021

  • Sector

    Healthсare

  • Industry

    Health Care Providers & Services

  • Employees

    3052

  • City

    Wuhan

  • Address

    Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone

  • Cusip

    G5262E104

9960.HK market tickers

OOTC - OTC

KDGTF

Frequently Asked Questions

What sector does Kindstar Globalgene operate in?

Kindstar Globalgene operates in Healthсare sector

What is market cap of Kindstar Globalgene?

Market cap of Kindstar Globalgene is 0.171 USD as of 24 Jul 2024

What is market price of one 9960 stock?

Market price of one 9960 stock is 1.3 HKD as of 24 Jul 2024

What is Kindstar Globalgene revenue?

According to the recent report Kindstar Globalgene revenue is 492.76

What is Kindstar Globalgene net income?

According to the recent report Kindstar Globalgene net icnome is 43.982

What is Kindstar Globalgene net income growh rate?

Net income growth rate of Kindstar Globalgene is -27